arrow
I

Iván Noreña

university of munich
H指数:8
被引数:164

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Refining research outcomes: Lessons from the setup of an endpoint review committee and radiological review in tuberculosis observational diagnostic studies

优化研究结果的提炼:结核病观察性诊断研究终点审查委员会及放射学审查的经验教训

2026-04-300
PRE
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial

Sutezolid与bedaquiline、delamanid和moxifloxacin联合治疗肺结核(PanACEA-SUDOCU-01):一项前瞻性、开放标签、随机、Ⅱb期剂量探索试验

2025-07-080
OAAI
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial

德尔帕索利德联合贝达喹啉、德拉马尼和莫西沙星治疗肺结核(PanACEA-DECODE-01):一项前瞻性、随机、开放标签、IIb期剂量探索试验

2025-07-080
OAAI
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB

Bedaquiline、Delamanid和Moxifloxacin与不同剂量的Sutezolid或Delpazolid联合或单独给药治疗药物敏感型结核病的 cardiac safety

2025-07-012
OA
Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections
2024-09-301
OAAI
Determinants of Anti-S Immune Response at 12 Months after SARS-CoV-2 Vaccination in a Multicentric European Cohort of Healthcare Workers-ORCHESTRA Project

欧洲多中心医护人员队列中SARS-CoV-2疫苗接种后12个月抗S免疫反应的决定因素-乐团项目

2023-09-264
OAAI
The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers
2023-07-183
OAAI
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
2023-07-133
OAAI
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S

Omicron变体感染对使用EUROIMMUN Quan-T细胞SARS-CoV-2测定法和Roche Elecsys Anti-SARS-CoV-2-S评估刺突特异性免疫反应的影响

2023-03-082
OAAI